Shares of Valeant Pharmaceuticals have slumped for the second straight trading day, erasing more than $6 billion US of market value from the drug company since last Thursday.
Shares of Valeant Pharmaceuticals have slumped for the second straight trading day, erasing more than $6 billion US of market value from the drug company since last Thursday.
0 commentaires:
Enregistrer un commentaire